| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $4.03B | +5.5% |
| Cost of Revenue | $2.71B | +6.7% |
| R&D Expense | $189.3M | +19.0% |
| SG&A Expense | $370.6M | +10.0% |
| Operating Income | $670.1M | +5.8% |
| Pre-tax Income | $396.7M | -4.2% |
| Income Tax | $86.0M | +70.9% |
| Net Income | $310.7M | -14.5% |
| EPS (Basic) | $2.00 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.23B | -28.3% |
| Accounts Receivable | $742.4M | +13.6% |
| Inventory | $644.9M | +9.6% |
| Current Assets | $2.78B | -9.8% |
| Total Assets | $8.76B | +1.7% |
| Current Liabilities | $1.18B | +41.0% |
| Long-term Debt | $4.25B | -0.1% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $460.6M | -16.9% |
| Investing Cash Flow | -$590.6M | +33.0% |
| Financing Cash Flow | -$353.5M | -302.1% |
| -13.0% |
| EPS (Diluted) | $1.99 | -12.7% |
| Total Liabilities |
| $5.65B |
| +2.3% |
| Stockholders' Equity | $3.11B | +0.5% |